Health Canada drug identification number

DIN 02475200 — LYNPARZA 100 MG

LYNPARZA is a tablet of Olaparib marketed by ASTRAZENECA CANADA INC. The full Olaparib monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02475200
Brand name
LYNPARZA
Active ingredient
Olaparib
Strength
100 MG
Dosage form
TABLET
Route
ORAL
Manufacturer
ASTRAZENECA CANADA INC
Health Canada status
MARKETED
Drug class
PARP inhibitor (antineoplastic agent)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Olaparib products

DINBrandStrengthFormManufacturerStatus
02475219 LYNPARZA 150 MG TABLET ASTRAZENECA CANADA INC MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.